Atlas Trials

A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease

Clinical trial NCT05687890 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05687890
Sponsor
Biocity Biopharmaceutics Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Kidney DiseaseIgA Nephropathy
Start date
2023-05-23
Primary completion
2024-11-30
Enrollment
255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.